VRTX
43
-4
RL
66
-2
PPL
52
-7
KR
40
3
MSI
60
2
DGX
39
-4
CSCO
56
3
MO
57
-3
BWA
42
-2
FIS
46
-2
CB
44
-3
NAVI
27
-3
MCHP
41
2
XOM
40
-2
O
30
-5
LRCX
45
2
MAT
60
-5
T
39
-6
WFC
71
-3
DE
40
-2
VRTX
43
-4
RL
66
-2
PPL
52
-7
KR
40
3
MSI
60
2
DGX
39
-4
CSCO
56
3
MO
57
-3
BWA
42
-2
FIS
46
-2
CB
44
-3
NAVI
27
-3
MCHP
41
2
XOM
40
-2
O
30
-5
LRCX
45
2
MAT
60
-5
T
39
-6
WFC
71
-3
DE
40
-2
Financhill
Back

Lexaria Bioscience 10K Form

Sell
18

LEXX
Lexaria Bioscience

Last Price:
2.27
Seasonality Move:
75.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-04-14 10Q LEXX/Lexaria Bioscience Quarterly
2021-01-14 10Q LEXX/Lexaria Bioscience Quarterly
2020-10-15 10K LEXX/Lexaria Bioscience Annual
2020-06-29 10Q LEXX/Lexaria Bioscience Quarterly
2020-04-03 10Q LEXX/Lexaria Bioscience Quarterly
2020-01-09 10Q LEXX/Lexaria Bioscience Quarterly

Receive LEXX News And Ratings

See the #1 stock for the next 7 days that we like better than LEXX

LEXX Financial Statistics

Sales & Book Value

Annual Sales: $226.21K
Cash Flow: $-1.29M
Price / Cash Flow: 0
Annual Sales: $0.64
Price / Book: 3.56

Profitability

EPS (TTM): -0.44000
Net Income (TTM): $-4.85M
Gross Margin: $194.71K
Return on Equity: -93.31%
Return on Assets: -85.62%

Lexaria Bioscience Earnings Forecast

Key Lexaria Bioscience Financial Ratios

  • The Gross Profit Margin over the past 18 years for LEXX is 86.07%.
  • The Selling, General & Administrative Expenses for LEXX have been equal to 1,353.61% of Gross Profit Margin.
  • The Research & Development expenses have been 1,620.94% of Revenue.
  • The Interest Expense is -0.32% of Operating Income.
  • The Net Earning history of LEXX is -2,946.33% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

Lexaria Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LEXX
Website: lexariabioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 58.27
Quick Ratio: 55.84

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LEXX Technical Analysis vs Fundamental Analysis

Sell
18
Lexaria Bioscience (LEXX) is a Sell

Is Lexaria Bioscience a Buy or a Sell?